ImpediMed Limited
IPDQF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $101,242 | $193,023 | $337,723 | $124,741 |
| - Cash | $22,183 | $24,632 | $45,710 | $40,730 |
| + Debt | $14,491 | $1,143 | $1,447 | $170 |
| Enterprise Value | $93,550 | $169,534 | $293,460 | $84,181 |
| Revenue | $12,724 | $10,053 | $11,344 | $10,495 |
| % Growth | 26.6% | -11.4% | 8.1% | – |
| Gross Profit | $10,975 | $8,739 | -$13,654 | $8,786 |
| % Margin | 86.3% | 86.9% | -120.4% | 83.7% |
| EBITDA | -$17,553 | -$22,051 | -$20,493 | -$18,768 |
| % Margin | -138% | -219.3% | -180.7% | -178.8% |
| Net Income | -$23,237 | -$19,790 | -$20,521 | -$19,874 |
| % Margin | -182.6% | -196.9% | -180.9% | -189.4% |
| EPS Diluted | -0.012 | -0.01 | -0.011 | -0.012 |
| % Growth | -17.3% | 14% | 3.4% | – |
| Operating Cash Flow | -$14,645 | -$17,789 | -$18,049 | -$15,664 |
| Capital Expenditures | -$989 | -$3,105 | -$6,043 | -$5,221 |
| Free Cash Flow | -$15,634 | -$20,894 | -$24,092 | -$20,885 |